Goldman Sachs Group Inc Scholar Rock Holding Corp Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,720,582 shares of SRRK stock, worth $67.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,720,582
Previous 1,399,202 22.97%
Holding current value
$67.4 Million
Previous $11.2 Million 563.54%
% of portfolio
0.01%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$7.07 - $45.73 $2.27 Million - $14.7 Million
321,380 Added 22.97%
1,720,582 $74.4 Million
Q3 2024

Nov 14, 2024
BUY
$7.63 - $9.71 $458,723 - $583,774
60,121 Added 4.49%
1,399,202 $11.2 Million
Q2 2024

Aug 13, 2024
BUY
$7.84 - $16.79 $838,370 - $1.8 Million
106,935 Added 8.68%
1,339,081 $11.2 Million
Q1 2024

May 15, 2024
SELL
$13.2 - $17.76 $2.62 Million - $3.53 Million
-198,618 Reduced 13.88%
1,232,146 $21.9 Million
Q4 2023

Feb 13, 2024
BUY
$6.52 - $20.32 $2.23 Million - $6.96 Million
342,690 Added 31.5%
1,430,764 $26.9 Million
Q3 2023

May 14, 2024
SELL
$6.02 - $7.76 $2.06 Million - $2.66 Million
-342,690 Reduced 23.95%
1,088,074 $7.73 Million
Q3 2023

Nov 14, 2023
SELL
$6.02 - $7.76 $1.82 Million - $2.35 Million
-302,731 Reduced 21.77%
1,088,074 $7.73 Million
Q2 2023

May 14, 2024
BUY
$5.79 - $9.11 $2 Million - $3.15 Million
346,068 Added 33.12%
1,390,805 $10.5 Million
Q2 2023

Aug 14, 2023
BUY
$5.79 - $9.11 $2 Million - $3.15 Million
346,068 Added 33.12%
1,390,805 $10.5 Million
Q1 2023

May 14, 2024
BUY
$7.36 - $12.72 $5.68 Million - $9.82 Million
772,148 Added 283.26%
1,044,737 $8.36 Million
Q1 2023

May 11, 2023
BUY
$7.36 - $12.72 $5.68 Million - $9.82 Million
772,148 Added 283.26%
1,044,737 $8.36 Million
Q4 2022

May 14, 2024
SELL
$7.02 - $9.76 $1.06 Million - $1.47 Million
-150,848 Reduced 35.62%
272,589 $2.47 Million
Q4 2022

Feb 13, 2023
SELL
$7.02 - $9.76 $1.06 Million - $1.47 Million
-150,848 Reduced 35.62%
272,589 $2.47 Million
Q3 2022

May 14, 2024
BUY
$5.33 - $11.3 $1.37 Million - $2.91 Million
257,727 Added 155.53%
423,437 $2.94 Million
Q3 2022

Nov 10, 2022
BUY
$5.33 - $11.3 $1.37 Million - $2.91 Million
257,727 Added 155.53%
423,437 $0
Q2 2022

May 14, 2024
SELL
$4.66 - $13.96 $5.9 Million - $17.7 Million
-1,265,054 Reduced 88.42%
165,710 $909,000
Q2 2022

Aug 15, 2022
BUY
$4.66 - $13.96 $71,712 - $214,830
15,389 Added 10.24%
165,710 $909,000
Q1 2022

May 16, 2022
BUY
$11.89 - $24.68 $1.25 Million - $2.6 Million
105,413 Added 234.73%
150,321 $1.94 Million
Q4 2021

Feb 14, 2022
BUY
$24.14 - $35.18 $275,823 - $401,966
11,426 Added 34.13%
44,908 $1.12 Million
Q3 2021

Nov 10, 2021
BUY
$27.38 - $42.21 $916,737 - $1.41 Million
33,482 New
33,482 $1.11 Million

Others Institutions Holding SRRK

# of Institutions
257
Shares Held
88.6M
Call Options Held
1.82M
Put Options Held
1.17M
View Full List

About Scholar Rock Holding Corp

SRRK Quotes by TradingView
  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.02B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email